2019 M&A Deals: A Transaction Recap

Morse is pleased to announce that the Firm had a stand-out year for M&A deals in 2019, completing 22 transactions totaling just under $1 billion. The average deal size was $41 million. Additional deal data was reported on the Morse website, including an industry break-down which shows a strong year for healthcare/life sciences and technology …

Register today: Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances

  The MBBP Life Sciences group will host the panel event Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances on Wednesday, April 3 in our Waltham office. Topics will include upfront license fees, technology access payments, milestone triggers, commercial due diligence fees, clinical trial milestones, royalty rates, and more. …

MassBio Forum: Doing Business in China, Trade Friction or Pharma Fusion?

By: John Hession This week I attended a MassBio Forum Panel on Doing Business With China: Changing Regulatory Reforms and BD Opportunities in China. The panel members were Kate Haviland, Chief Business Officer at Blueprint Bio; Wei Zhao, Vice President at VP 6 Dimensions (Wuxi Ventures); and Kenneth Zhou, Partner at WilmerHale. The moderator was Ryan Roller, …

Recent Growth in the Boston Area Life Sciences Ecosystem

The life sciences ecosystem in Boston is flourishing at a prolific pace. Boston is the mecca of strong universities coupled with some of the top teaching hospitals in the country, producing imaginative, intelligent individuals with science and medical backgrounds. These researchers and entrepreneurs are driven to launch the latest groundbreaking ideas and devices to fight …

Life Sciences Vector Newsletter, Spring 2018

Our Life Sciences team has published the Spring 2018 edition of its Vector newsletter. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information. JOSEPH HUNT AND DANIEL BLANCHARD JOIN FIRM IN TAX AND CORPORATE PRACTICE GROUPS A member of the Firm’s Corporate and Tax Practice Groups, …

2018 Tax Reform: Life Sciences Update – April 24

Register today! On April 24th in our Waltham office, MBBP and Withum will host the 2018 Tax Reform: Life Sciences Update. Just like the life sciences industry is constantly changing and evolving, the 2017 Tax Cuts and Jobs Act has done the same to the U.S. tax code. During this seminar, Shawn C. Henderson, CPA, …

Carl Barnes Comments on Earnout Disputes in Startup Acquisitions in Wall Street Journal

The Wall Street Journal article "Rise of 'Earnouts' Muddies M&A Waters" discusses the increasing landscape of earnout agreements in startup acquisitions. As the article states, earnout agreements are often used in order to settle differences over a company's valuation, but are frequently leading to disputes over milestone payments. MBBP corporate partner Carl Barnes remarks that: …

MBBP’s Life Sciences Vector Newsletter, Summer 2017

Our Life Sciences team has published the Summer 2017 edition of its Vector newsletter. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information. CORPORATE PARTNER MIKE JABBAWY PARTICIPATING ON SHOOBX STARTUP PANEL On September 26, corporate partner Mike Jabbawy will take part in the panel “How …

More Money for Life Sciences?

By: Erin Bryan A new legislative proposal to provide a five-year, $500 million life sciences initiative was recently announced by Governor Charlie Baker. This initiative would extend the current 10-year, $1 billion initiative that is set to expire at the end of the next fiscal year and would continue to be managed by the Massachusetts …

David Sabatini To Be Awarded 2017 Dickson Prize in Medicine

Biologist David Sabatini of MBBP client Whitehead Institute will receive the University of Pittsburgh's 2017 Dickson Prize in Medicine. The Dickson Prize in Medicine is awarded annually to a leading American investigator who is engaged in innovative, paradigm-shifting biomedical research. Sabatini discovered mTOR, a key cellular regulatory metabolic pathway. In addition to being a member of …